Organovo Holdings Inc ONVO:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/22/21 EDT
7.32quote price arrow up+0.46 (+6.71%)
Volume
81,627
52 week range
6.02 - 23.92
Loading...
  • Open6.91
  • Day High7.41
  • Day Low6.91
  • Prev Close7.32
  • 52 Week High23.92
  • 52 Week High Date02/11/21
  • 52 Week Low6.02
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap63.76M
  • Shares Out8.71M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change-40.49

KEY STATS

  • Open6.91
  • Day High7.41
  • Day Low6.91
  • Prev Close7.32
  • 52 Week High23.92
  • 52 Week High Date02/11/21
  • 52 Week Low6.02
  • 52 Week Low Date09/24/20
  • Market Cap63.76M
  • Shares Out8.71M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change-40.49

RATIOS/PROFITABILITY

  • EPS (TTM)-2.36
  • P/E (TTM)-3.10
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-13.726M
  • ROE (MRQ)-53.41%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)95.64%
  • Net Margin (MRQ)-5,977.18%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/07/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Organovo Holdings Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Organovo Holdings, Inc. is an early stage biotechnology company. The Company is focused on building high fidelity, three-dimensional (3D) tissues that recapitulate key aspects of human disease. The Company is targeting the intestine and has ongoing 3D tissue developments in Ulcerative colitis (UC) and Crohn's disease (CD). The Company uses its platform technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture...
Keith Murphy
Chairman
Jonathan Lieber
President
Thomas Jurgensen J.D.
General Counsel
Address
440 Stevens Avenue, Suite 200
Solana Beach, CA
92075
United States

Top Peers

SYMBOLLASTCHG%CHG
MNPR
Monopar Therapeutics Inc
5.12-0.03-0.58%
SYN
Synthetic Biologics Inc
0.48+0.02+4.35%
RZLT
Rezolute Inc
8.07-0.16-1.94%
CLBS
Caladrius Biosciences Inc
1.20+0.02+1.69%
NERV
Minerva Neurosciences Inc
1.68-0.07-4.00%
NDRA
ENDRA Life Sciences Inc
1.79+0.14+8.48%